Prevalence of Hepatitis C Antibodies Among Hemodialysis Patients in Al-Hasa Region of Saudi Arabia

• Main Authors: Saxena Anil, Panhotra B, Naguib Mohamed, Aboras Mohammed, Sundaram D, Venkateshappa C, Khan Wahid
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2001-01-01
• Series: Saudi Journal of Kidney Diseases and Transplantation
• Subjects: Hepatitis C virus; Hemodialysis; Al-Hasa; Saudi Arabia.
• Online Access: http://www.sjkdt.org/article.asp?issn=1319-2442;year=2001;volume=12;issue=4;spage=562;epage=565;aulast=Saxena

The prevalence of anti-HCV antibodies among hemodialysis (HD) patients was studied at King Fahad Hospital, Hofuf, Saudi Arabia. The records of 189 patients undergoing HD were reviewed. The overall prevalence of anti-HCV antibodies was 43.9%. Anti-HCV antibody prevalence was more common among female patients. There was no correlation between repeated blood transfusions and anti-HCV positivity as 4.8% of the patients who did not receive any blood transfusion during HD were positive for anti-HCV antibodies. A positive correlation was observed between the duration on dialysis and anti-HCV antibodies. An annual serocoversion rate of 6.8% was observed in this study.